Research Centers

Marie-Louise G Wadenberg, PhD


Academic Title
Adjunct Researcher/Lecturer
Department Chemistry & Biomedical Sciences
Linnaeus University, Kalmar Sweden

Contact Information
Office Phone: +46 (0)772-28 80 00
Direct Phone: +46 (0)480-447361
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.




Research Projects:

Augmentation strategies for improvement of pharmacological treatment in schizophrenia: focus on cognition.

Current Grants:
Swedish Brain Foundation (Hjärnfonden), Sweden. Project: Experimental strategies for improvement of cognitive impairment in schizophrenia by selective α7 nicotinic receptor ligands. Applicant of the scientific proposal with Dr. Hugo Arias (Co-applicant). August, 2014-July, 2015. Total: SEK 500,000 (~$77,000). Pending.

Publications (most representatives in the last 3 years)
Marie-Louise G. Wadenberg, Ann-Kristin Fjällström, Malin Federley, Pernilla Persson and Pia Stenqvist (2011) Effects of adjunct galantamine to risperidone, orhaloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor. The Int J Neuropsychopharmacol 14:644-654

M-L G Wadenberg, A W Khan, S B Koritala (2012) Effects of an adjunct nicotinic alpha7 receptor agonist to the atypical antipsychotic risperidone in animal models of antipsychotic activity and extrapyramidal side effect liability. CINP (Abstract, Stockholm).

M-L G Wadenberg (2013) Galantamine reverses acute phencyclidine-induced attentional set-shifting impairment in rats with retained effect also in the presence of risperidone. Int Congr of Schiz Res (Abstract, Orlando, Florida)

Wadenberg M-L G (2010) Conditioned avoidance response in the development of new antipsychotics. Curr Pharm Design 16:358-370.

California Northstate University College of Medicine ♦ 9700 West Taron Drive ♦ Elk Grove, CA 95757 ♦ Phone: (916) 686-7300